Anavex Life Sciences Corp (AVXL)

[end2war]

I don't know what you mean by your "Ariana massaging" comment, sorry.

In talking about deep dives, I was thinking about his attention to genetic proclivities of the Apoe4 variety, and his approach to AD via "precision medicine" that other AD researchers eschew or have not tried to fully work out.

It just seems to me he is attempting to understand what the data will ultimately show to explain more correlations that some others.

Where BIIB studied subgroups to argue for Aduhelm's approval as an afterthought; it seems that Missling is looking at subgroups up front, like how the drug affects Apeo4 type and other genetic groups.